Motolimod (VTX-2337) is a novel TLR8 agonist that activates NK cells and augments ADCC.
Product Name: Motolimod (VTX-2337)|Cat No.:DC8815|CAS: 926927-61-9|Other names: VTX 2337,VTX2337|MW: 458.6|C28H34N4O2
VTX-2337 is a novel small-molecule TLR8 agonist that activates monocytes, DCs, and NK cells. Through the activation of NK cells, it has the potential to augment the effectiveness of monoclonal antibody treatments where a polymorphism in FcγR3A limits clinical efficacy.
For research only, not for human use!
没有评论:
发表评论